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ABSTRACT 
Objective: The objective of this study was to evaluate the disease prevalence and drug utilization pattern in the department of cardiology in a 
tertiary care hospital in northeastern India. 
Methods: Indoor case papers 112 of patients fulfilling inclusion criteria were included in this study. The study was performed in between 
December 2014 to February 2015. Case papers analyzed and documented for demographic variables, indication, disease prevalence, co-morbidities 
and prescribing pattern of the physician.  
Results: A total of 112 cases were evaluated. Patients of age group between 61-90 y were diagnosed 48.21% of cardiovascular diseases (CVDs). 
Male patients (67%) were diagnosed CVDs more than female patients (33%). Our findings indicated that hyperlipidemia (84.82%), hypertension 
(80.35%) and ischemic heart disease (66.96%) were most frequently diagnosed disease and most of the diseases were treated by the combination 
of two or three drugs. The use of statins, beta blockers, diuretics, calcium channel blockers and angiotensin-converting enzymes (ACE) inhibitors 
was very common. Diabetes, anemia and asthma were the comorbidities associated with CVDs. 
Conclusion: Hyperlipidemia, hypertension and ischemic heart disease were the prevalent diseases among CVDs. Statins and antihypertensive were 
most prescribed drugs. Combinations of drugs were prescribed to the patients for effective therapy. The present study will help the healthcare 
professionals to optimize the efficient and safe use of cardiovascular drugs. 
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INTRODUCTION 
Drug utilization pattern study is a powerful exploratory tool to 
evaluate present trends of drug use and appropriateness of 
prescriptions. It is a descriptive and analytical method of collection, 
quantification, understanding and evaluation of the prescribing 
pattern, as well as dispensing and consumption for the advancement 
of existing therapy and enhancement of patient safety [1]. Nowadays 
inappropriate drug use is a common hurdle which receives the 
support of numerous worldwide research studies to determine the 
safe and effective drug utilization [2].  
These studies are rising globally in different healthcare settings; 
provide enormous medical, social and economic significance. Drug 
utilization research helps in the management of drug-specific 
problems, and the evaluation of the appropriateness of drug therapy 
[3]. Identification and assessment of the prescribing pattern are one 
of the very first steps towards improving both medication quality 
and patient safety. Medication quality and patient, safety requires a 
rational prescription of medication and avoidance of inappropriate/ 
irrational prescribing patterns [4]. Rational prescription of drugs 
means an efficient and safe drug according to clinical needs for an 
adequate period and at the minimum available cost. Prescribing 
unnecessarily branded drugs, the cost issue, inadequate drugs 
supply, and lack of patient counseling regarding dosing schedules 
and possible side effects are the major causes of irrational use of 
drugs [5], which may lead to failure of therapy and undesirable side 
effects [4]. Triad of right diagnosis, accurate prescription and 
excellent patient counseling leads to the effective and safe use of the 
drug. Also prescribing multiple drugs not only results of the cost and 
regimens complication but also increases the incidence of 
undesirable side effects and drug-drug interactions. Cardiovascular 
diseases (CVDs) are still the leading cause of death globally. The 
Global Burden of Disease study estimated that 29.6% of all deaths 
worldwide (15616.1 million deaths) were caused by CVD in 2010, 
more than all communicable, maternal, neonatal and nutritional 
disorders combined, and double the number of deaths caused by 
cancers [6]. It was reported that by 2015 approximately 20 million 
patients will die mainly due to heart disease [7, 8]. The elevated 
levels of blood cholesterol, hypertension, smoking, excessive alcohol 
consumption, diabetes, obesity and malnutrition, etc. are some of the 
risk factors for CVDs [8].  
Previous studies reported different preventive strategies related to 
the rational use of drugs have been taken by developed countries 
which reduced the risk associated with the occurrence of CVDs [9], 
also reported that population-based prescribing trends have a 
significant impact on patient health. Nonetheless, the studies in 
developing countries are insufficient and incomplete in nature, 
particularly in tertiary care setups. [10]. In the present study, we 
examined the disease prevalence and prescribing trends and various 
co-morbidities among the inpatient admitted to the department of 
cardiology in northeastern India.  
MATERIAL AND METHODS 
The present study was performed to understand the prescription 
pattern and to analyze the utilization of different classes of drugs 
in inpatients, admitted to the department of cardiology, of Guahati 
Medical College and Hospital (GMC & H), Guwahati, Assam. The 
study was approved by the Institutional Ethics Committee 
(approval no. MCI/233/2013/349). Patients (age 30-90 y) 
suffering from CVDs and admitted in the department of cardiology 
with informed consent were included in the study as study 
populations. Patient referred from other hospitals within one 
week was also included in the survey. Patients with incomplete 
case record form and transferred to other units within a day of 
admission from the department of cardiology were excluded. Drug 
prescription was collected, and documented in Microsoft Excel 
sheet and further analyzed. Documented datum was analyzed by 
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using Graph pad Prism version 5.0. Non-parametric values were 
expressed as the percentage. 
Study population 
This observational study was held from December 2014 to February 
2015. In total 126 patients were identified and 112 patients were 
recruited for further study as they fulfill all inclusion criteria. Study 
subject medical record and prescription were examined on the 
regular hospital visit to the department of cardiology GMC & H 
Guwahati Assam. Data collection was based on prescriptions which 
were issued to them in which all the patients are designated by 
names, age, gender and other necessary information. 
RESULTS  
A total of 112 patients with cardiovascular disease were included in 
which male patients (67%) had a high frequency of cardiovascular 
incidence as compared to female patients (33%) as showed in fig. 1. 
In our study out of 112 patients, 21.42 % of patients belong to the 
ages group of 30-40 y, 30.35 % of patients belongs to the age groups 
of 41-60 y while 48.21 % of patients belongs to the age groups of 61-
90 y as mentioned in table 1. 
 
 
Fig. 1: Percentage of male and female patients
 
Table 1: Age groups of the patients (n=112) 
Age group (in years) Male Female Total Percentage (%) 
30-40 16 8 24 21.42 
41-60 24 10 34 30.35 
61-90 36 18 54 48.21 
Hyperlipidemia, ischemic heart disease (IHD) and hypertension (HTN) were the most diagnosed disease among 112 patients, 84.82 % patients were 
diagnosed with hyperlipidemia, 66.96 % patients with IHD, 80.35 % patients with HTN, and 35.71% with myocardial infarction (MI) as shown in table 2.  
 
Table 2: Percentages of different diseases found in patients (n=112) 
Medical conditions No. of patients Percentage (%) 
Ischemic heart disease 75 66.96 
Hypertension 90 80.35 
Myocardial infarction 40 35.71 
Hyperlipidemia 95 84.82 
Heart failure 28 25 
 
Co-morbidity assessment 
In the present study, doctors diagnosed some comorbidity like 
diabetes, asthma, etc.; in a number of cardiovascular patients. The 
most frequently encountered comorbidities were diabetes, anemia 
and asthma. In total 112 subjects, 100 with diabetes (89.28%), 54 
patients with asthma (48.21%) and 75 patients with anemia 
(66.96%) were reported during the study period (table 3). 
 
Table 3: Co-morbidity assessment (n=112) 
Co-morbidity Male Female Total Percentage (%)  
Diabetes 65 35 100 89.28  
Asthma 30 24 54 48.21  
Anemia 21 54 75 66.96  
 
Drug utilization pattern 
Fig. 2, indicated that 7% patients were prescribed with a single drug 
while 44% patients were prescribed two drugs and 36% patients 
and 13% patients were found to be prescribed with three and four 
medications respectively.  
 
 
Fig. 2: Percentages of drugs used alone and in combinations 
Fig. 3, showed the prescribing pattern of different cardiovascular 
drugs. Results indicated that most commonly prescribed drugs were 
found to be the beta blocker (84 %), statins (68 %), diuretics (40 %), 
calcium channel blocker (35%), ACE Inhibitors (42 %) and 
antiplatelet (34 %). 
Antihyperlipidemic drugs 
Among the antihyperlipidemic drugs, atorvastatin was prescribed to 
most of the patients (66.96%) while the second choice was 
rosuvastatin (22.32%) (table 4).  
Antihypertensive drugs 
Antihypertensive drugs were the most prescribed drugs for the 
CVDs patients. Among different classes of the antihypertensive 
drugs most preferred class were beta-blockers, diuretics, calcium 
channel blocker and ACE inhibitors. Most of the doctors’ prescribed 
single agent rather than combinations. Metoprolol (61.66%) and 
carvedilol (44.44%) were the first choices for the patients. On the 
other hand combination of beta blocker and calcium channel blocker 
was prescribed to the minority (18.75%) of the patients (table 4). 
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Fig. 3: Prescribing pattern of the physicians in cardiovascular 
patients (n=112), A = Antianginal; B = Diuretic; C = ACE Inhibitor; D 
= Beta-blockers; E = Statin; F = Antiplatelet; G = Anticoagulant; H = 
Vasorelaxant; I = Calcium Channel Blocker; J = Miscellaneous 
 
Patients were also prescribed ACE inhibitors and diuretics might be 
due to the widening of the indications such as hypertension, diabetic 
nephropathy and heart failure, etc. 
Anti-ischemic drugs 
The combination of antiplatelet drugs clopidogrel and aspirin was 
prescribed to 48.36% for synergistic activity whereas 37.21% 
patients were treated with only clopidogrel. Aspirin and warfarin 
were prescribed to only 10.12% and 4.33% patients, respectively. 
Anti-ischemic agents such as direct vasodilators were used 
commonly. Nitroglycerine was prescribed in 30.35% patients 
whereas the combination of isosorbide mononitrate and 
nitroglycerine was prescribed in 47.32% patients. Calcium channel 
blockers such as amlodipine and diltiazem were also prescribed 
frequently (table 4). 
DISCUSSION 
A survey based on the prescription is considered to be one of the 
most cost-effective methods to determine the prescribing 
approach of physicians [11]. The first and third leading cause of 
death among adult age group is CVDs and stroke [12]. This study 
was carried out at a tertiary care hospital in northeastern India. 
Clinical studies on drug utilization which allows different 
treatment choice of the specialists in the CVDs patients are quite 
uncommon in developing nations.  
Previous studies explain the gender gap in CVDs and the rapid 
increase in CVDs mortality among middle-aged men. Men 
develop CVDs more frequently than age-matched women [13]. 
 
Table 4: Different classes of drugs prescribed to the cardiovascular patients (n=112) 
Drugs No. of prescription Prescription rate (%) 
Beta blockers   







Antihyperlipidemic   
Atorvastatin 75 66.96 
Rosuvastatin 25 22.32 
Simvastatin 14 12.5 
Anti-atherogenic   
Clopidogrel 44 39.28 
Aspirin 23 20.53 
Clopidogrel+Aspirin 56 50 
Warfarin 14 12.5 
Streptokinase 32 28.57 
Diuretic   
Frusemide 66 58.92 
Spironolactone 13 11.60 
Antianginal   
Nitroglycerine 34 30.35 
Isosorbide mononitrate 24 21.42 
Nitroglycerine+Isosorbide mononitrate 53 47.32 
Miscellaneous   
Proton pumps inhibitors 34 30.35 
Anxiolytics 12 10.71 
Ferrous sulphate 26 23.21 
 
Among all CVDs, coronary artery disease (CAD) is widely 
documented disease in older males. Also, comparisons between the 
sexes revealed that the differences in psychosocial and behavioral 
coronary risk factors in men and women. The psychosocial and 
behavioral coronary risk factors favor women, which show women’s 
coping with a stressful environment may be more cardioprotective 
[14]. These studies were supported by our findings in which male 
patients are more prone to cardiovascular incidence as compared to 
female patients. The impact of CVDs increases with age in both 
sexes. People with the age of<50 y having the chance of CVDs 
11/100,000 and 4/100,000 in men and women, respectively while 
the age of<75 y this rate increases to 120/100,000 men and 
60/100,000 women [15]. In the present study, 48.21% of patients 
belong to the age group of 61-90 y which strengthens the previous 
studies which showed a high incidence of CVDs in older people. 
Earlier research in the United States reported approximately 74.5 
million cases were related to hypertension, followed by 17.6 million 
and 6.4 million cases of coronary heart disease and stroke 
respectively [16]. Among 122 patients half of the patients were 
diagnosed with hyperlipidemia, which is the key risk factor for 
coronary heart diseases (CHDs). The elevated blood cholesterol level 
may be due to bad food habits, less physical exercise, poor health 
hygiene and urbanization. One previous study reported that 
hypertension is the second leading disease among CVDs if untreated 
may lead to diseases such as heart failure, stroke, and myocardial 
infarction, etc. [17]. During present study different adjustable 
related risk factors were also determined which may be associated 
with CVDs particularly bad food habits, alcohol intake, physical 
inactivity, smoking and obesity. Patients with diabetes mellitus (DM) 
as co-morbid diseases are frequently confound hypertension, which 
increases its morbidity and mortality [18]. Type II DM is a co-morbid 
disease and independent risk factor for cardiovascular disease. 
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There is an increasing body of data from clinical trials revealed that 
strict control of blood pressure to levels<140/90 mm Hg 
significantly reduces CVD morbidity and mortality in patients with 
type 2 DM [19]. These previous reports were supported by the 
present study where DM was frequently occurring co-morbid 
disease among CVDs patients.  
Beta blockers are a class of drugs, which are used primarily in 
hypertension. Antihypertensive and cardioprotective effects β-
blockers support more frequently use as found in our study. In a 
previous study by Heaton et al. [20] reported that beta blockers 
decrease the mortality rate in myocardial infarction patient. Cardio-
selective β blockers, metoprolol and carvedilol, were the most 
prescribed drugs in the present study which was a rational approach 
to the therapy. With an objective to control various complications of 
CVDs patients were prescribed the combination of drugs. Physicians 
mostly prescribed dual and triple drug regimen. Patients were 
advised to do physical exercise with daily blood pressure 
monitoring. Our study showed that most of the hyperlipidemic 
patients were prescribed atorvastatin which decreases blood LDL 
cholesterol level while increasing the HDL level. In addition, it also 
reduces the risk of CHD, MI and stroke, etc. [21]. The patients with 
ischemic heart disease were treated with antiplatelet drugs which 
prevent blood clotting or atheroma. Atheroma in coronary blood 
vessels may lead to a sudden heart attack or myocardial infarction. 
Drugs like antiplatelet agents are used individually or in the 
combination for prevention as well as terminating the heart attack. 
In the present study antiplatelet drugs such as clopidogrel, aspirin 
and nitrates such as nitroglycerine, isosorbide mononitrate was 
used most frequently in IHD patients. 
CONCLUSION 
In the present study, the prevalence of IHD and hypertension was 
high. The male patient with an age group of 60-90 y was most 
affected and admitted to the department of cardiology. Statins, beta 
blockers, diuretics, calcium channel blocker and ACE inhibitors were 
the most frequently prescribed drugs. The use of anticoagulants and 
anti-platelet is value addition in the effective treatment as well as 
prevention of ischemic heart diseases. Moreover, time to time 
studies is required to assess drug utilization pattern for improving 
disease management strategy and quality of life of patients. In order 
to achieve optimal therapeutic outcomes unnecessary multifaceted 
prescription must be avoided. In addition from regular workshops 
or seminars for the health care professionals and dissemination of 
treatment guidelines could facilitate rational use of the drug.  
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